Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Medical Specialties (16)
- Oncology (15)
- Diseases (12)
- Medical Sciences (11)
- Other Chemicals and Drugs (11)
-
- Life Sciences (8)
- Organic Chemicals (6)
- Pharmaceutical Preparations (6)
- Pharmacy and Pharmaceutical Sciences (6)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (5)
- Biological Factors (5)
- Biochemistry, Biophysics, and Structural Biology (4)
- Biological Phenomena, Cell Phenomena, and Immunity (4)
- Enzymes and Coenzymes (4)
- Medical Cell Biology (4)
- Pharmaceutics and Drug Design (4)
- Medicinal and Pharmaceutical Chemistry (3)
- Nanotechnology (3)
- Natural Products Chemistry and Pharmacognosy (3)
- Neoplasms (3)
- Physical Sciences and Mathematics (3)
- Therapeutics (3)
- Alternative and Complementary Medicine (2)
- Amino Acids, Peptides, and Proteins (2)
- Cancer Biology (2)
- Cell and Developmental Biology (2)
- Chemical Actions and Uses (2)
- Chemistry (2)
- Institution
-
- University of Texas Rio Grande Valley (5)
- Duquesne University (3)
- Virginia Commonwealth University (3)
- Belmont University (2)
- Louisiana State University (2)
-
- University of Central Florida (2)
- University of Mary Washington (2)
- Advocate Health - Midwest (1)
- Bellarmine University (1)
- Bridgewater State University (1)
- California State University, San Bernardino (1)
- Edith Cowan University (1)
- Georgia Southern University (1)
- Marshall University (1)
- Old Dominion University (1)
- Philadelphia College of Osteopathic Medicine (1)
- Rowan University (1)
- St. John Fisher University (1)
- Technological University Dublin (1)
- The British University in Egypt (1)
- The Texas Medical Center Library (1)
- The University of San Francisco (1)
- University of Kentucky (1)
- University of Nevada, Las Vegas (1)
- University of Tennessee Health Science Center (1)
- Western Kentucky University (1)
- Publication Year
- Publication
-
- School of Medicine Publications (4)
- Departmental Honors & Graduate Capstone Projects (2)
- Electronic Theses and Dissertations (2)
- Honors Undergraduate Theses (2)
- SPARK Symposium Presentations (2)
-
- Theses and Dissertations (2)
- AUCTUS: The Journal of Undergraduate Research and Creative Scholarship (1)
- Chemistry & Biochemistry Faculty Publications (1)
- D.U.Quark (1)
- Dissertations and Theses (Open Access) (1)
- Doctoral (1)
- Electronic Theses, Projects, and Dissertations (1)
- Health & Biomedical Sciences Faculty Publications (1)
- Honors College Theses (1)
- Honors Program Theses and Projects (1)
- Internal Medicine Faculty Publications (1)
- Journal of Patient-Centered Research and Reviews (1)
- LSU Doctoral Dissertations (1)
- LSU Master's Theses (1)
- Master's Projects and Capstones (1)
- Masters Theses & Specialist Projects (1)
- PCOM Physician Assistant Studies Student Scholarship (1)
- Pharmacy (1)
- Research outputs 2022 to 2026 (1)
- Rowan-Virtua Research Day (1)
- The Review: A Journal of Undergraduate Student Research (1)
- Theses and Dissertations (ETD) (1)
- Theses, Dissertations and Capstones (1)
- UNLV Theses, Dissertations, Professional Papers, and Capstones (1)
- Undergraduate Theses (1)
- Publication Type
Articles 31 - 38 of 38
Full-Text Articles in Chemicals and Drugs
Discovery Of Pyrimidine-Based Heterocycles As Single Agents With Combination Chemotherapy Potential And As Inhibitors Of Purine Nucleotide Biosynthesis For The Treatment Of Cancer, Rishabh Mohan
Electronic Theses and Dissertations
This dissertation describes the design, synthesis and biological evaluation of monocyclic and bicyclic pyrimidine-base heterocycles as single agents with combination chemotherapy potential having both antiangiogenic effects and cytotoxic effects. This dissertation also describes selective tumor targeting with 5-substituted pyrrolo[2,3-d]pyrimidines analogs with heteroatom bridge substitution as GARFTase inhibitors.
The work in this dissertation is centered on identifying structural features that are necessary for inhibition of tubulin polymerization as well as for inhibition of one or more of the receptor tyrosine kinases (RTKs)- vascular endothelial growth factor receptor-2 (VEGFR2), platelet derived growth factor receptor-β (PDGFRβ) and epidermal growth factor receptor …
Cancer Stem Cells In The Screening Of Anticancer Drugs For Central Nervous System Tumors, Sarah Elizabeth Daron-Mathis
Cancer Stem Cells In The Screening Of Anticancer Drugs For Central Nervous System Tumors, Sarah Elizabeth Daron-Mathis
Theses, Dissertations and Capstones
There is a growing need (in the medical field) to design personalized therapy for cancer patients. Decades of cancer research have found no silver bullet that can cure all or even most patients. This study evaluated four patients affected by central nervous system (CNS) tumors (Ependymoma and Glioblastoma), and found that tumors with the same histology had unique responses to treatment. Each sample presented different levels of heterogeneity in expressed biomarkers and responded to drugs at varying levels.
Oncologists conventionally treat cancer patients with drugs tested in large clinical trials. However, often patients do not experience positive outcomes following treatments …
Cardiovascular Toxicity Of Common Chemotherapy Drugs Used To Treat Breast Cancer: An Overview, Charles A. Bomzer
Cardiovascular Toxicity Of Common Chemotherapy Drugs Used To Treat Breast Cancer: An Overview, Charles A. Bomzer
Journal of Patient-Centered Research and Reviews
Treatment of breast cancer often exposes patients to many different drugs. Some of these drugs have toxic effects involving the cardiovascular system. This review provides an overview of the drugs most commonly used to treat breast cancer and their potential adverse impact on the cardiovascular system.
Does The Addition Of Muramyl Tripeptide To Chemotherapy Improve Overall Survival For Patients With Osteosarcoma?, Jennifer Jones
Does The Addition Of Muramyl Tripeptide To Chemotherapy Improve Overall Survival For Patients With Osteosarcoma?, Jennifer Jones
PCOM Physician Assistant Studies Student Scholarship
OBJECTIVE: The objective of this selective EBM review is to determine whether or not “Does the addition of muramyl tripeptide to chemotherapy improve overall survival for patients with osteosarcoma?”
STUDY DESIGN: Review of three English language primary randomized controlled trials published between 2005 and 2009.
DATA SOURCES: Randomized controlled trials evaluating the addition of muramyl tripeptide (MTP) to chemotherapy for patients with osteosarcoma were found using Medline/PubMed databases.
OUTCOMES MEASURED: Event-free survival (EFS) and overall survival were the outcome measures used to determine the effectiveness of the additional chemotherapy treatment in osteosarcoma patients. EFS was defined as …
Inhibition Of Cysteine Protease By Platinum (Ii) Diamine Complexes, Chaitanya Rapolu
Inhibition Of Cysteine Protease By Platinum (Ii) Diamine Complexes, Chaitanya Rapolu
Masters Theses & Specialist Projects
Chemotherapy is the first line of treatment used in cancer. Chemotherapy drugs such as cisplatin, carboplatin and oxaliplatin are used in treatment. Cisplatin enters the cell through copper transporter CTR1 by passive diffusion and bind to DNA and proteins. Cisplatin is found to inhibit several enzymes targeting cysteine, histidine and methionine residues, which are expected to be responsible for its anticancer activity. A better understanding of how the size and shape and leaving ligands of platinum complexes affect cysteine protease, papain enzyme are studied. This could give new ways to optimize anticancer activity. The activity of papain enzyme was measured …
Specific, Reversible Cytostatic Protection Of Normal Cells Against Negative Effects Of Chemotherapy, Benjamin B. Mull
Specific, Reversible Cytostatic Protection Of Normal Cells Against Negative Effects Of Chemotherapy, Benjamin B. Mull
Dissertations and Theses (Open Access)
Chemotherapy is a common and effective method to treat many forms of cancer. However, treatment of cancer with chemotherapy has severe side effects which often limit the doses of therapy administered. Because some cancer chemotherapeutics target proliferating cells and tissues, all dividing cells, whether normal or tumor, are affected. Cell culture studies have demonstrated that UCN-01 is able to reversibly and selectively arrest normal dividing cells; tumor cells lines do not undergo this temporary arrest. Following UCN-01 treatment, normal cells displayed a 50-fold increase in IC50 for camptothecin; tumor cells showed no such increased tolerance.
We have examined the response …
Photochemical Delivery Of Bleomycin In Malignant Glioma Cells, Joseph William Blickenstaff Iii
Photochemical Delivery Of Bleomycin In Malignant Glioma Cells, Joseph William Blickenstaff Iii
UNLV Theses, Dissertations, Professional Papers, and Capstones
Despite continued efforts, glioblastoma multiforme (GBM) remains an incurable form of primary brain cancer. Surgical resection followed by radiation treatment and chemotherapy have been the most effective modalities in prolonging median survival time to 14 months. This research aims to study the response of two different cell culture models to a novel drug delivery method termed photochemical internalization (PCI). PCI is a technique to improve the utilization of macromolecules (e.g. the chemotherapeutic drug bleomycin) in site-specific cancer therapy. This concept is based on the use of specially designed photosensitizers (e.g. aluminum phthalocyanine disulfonate; AlPcS 2a ) which preferentially localize in …
Contribution Of Organic Cation Transporter 2 (Oct2) To Cisplatin-Induced Nephrotoxicity, Kelly K. Filipski
Contribution Of Organic Cation Transporter 2 (Oct2) To Cisplatin-Induced Nephrotoxicity, Kelly K. Filipski
Theses and Dissertations (ETD)
Cisplatin is the most widely used anticancer agent; however, the cellular pharmacokinetics are poorly understood. Cisplatin is predominantly eliminated through the urine via active secretion and is associated with nephrotoxicity. Currently, prehydration therapy is employed to prevent toxic renal side effects; however it has not been completely ameliorated. The studies described herein aim to determine the mechanism in which cisplatin enters the kidney cell from the blood and how it is subsequently secreted into the urine. Organic cation transporter 2 (OCT2) and ABCC2 are highly expressed in the kidney on the basolateral and apical membrane, respectively. We determined the contribution …